These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 32486166)
1. Albendazole-Induced SIRT3 Upregulation Protects Human Leukemia K562 Cells from the Cytotoxicity of MCL1 Suppression. Wang LJ; Liou LR; Shi YJ; Chiou JT; Lee YC; Huang CH; Huang PW; Chang LS Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486166 [TBL] [Abstract][Full Text] [Related]
2. Non-mitotic effect of albendazole triggers apoptosis of human leukemia cells via SIRT3/ROS/p38 MAPK/TTP axis-mediated TNF-α upregulation. Wang LJ; Lee YC; Huang CH; Shi YJ; Chen YJ; Pei SN; Chou YW; Chang LS Biochem Pharmacol; 2019 Apr; 162():154-168. PubMed ID: 30414389 [TBL] [Abstract][Full Text] [Related]
3. AMPK inhibition induces MCL1 mRNA destabilization via the p38 MAPK/miR-22/HuR axis in chronic myeloid leukemia cells. Lee YC; Chiou JT; Chang LS Biochem Pharmacol; 2023 Mar; 209():115442. PubMed ID: 36720359 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of EGFR pathway promotes the cytotoxicity of ABT-263 in human leukemia K562 cells by blocking MCL1 upregulation. Lee YC; Wang LJ; Huang CH; Chiou JT; Shi YJ; Chang LS Biochem Pharmacol; 2020 Aug; 178():114047. PubMed ID: 32446890 [TBL] [Abstract][Full Text] [Related]
5. CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells. Chiou JT; Huang CH; Wu TH; Wang LJ; Lee YC; Huang PW; Chang LS Toxicol Appl Pharmacol; 2022 Jan; 435():115847. PubMed ID: 34963561 [TBL] [Abstract][Full Text] [Related]
6. BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells. Chiou JT; Lee YC; Wang LJ; Chang LS Chem Biol Interact; 2022 Jul; 361():109978. PubMed ID: 35561756 [TBL] [Abstract][Full Text] [Related]
7. Autophagic HuR mRNA degradation induces survivin and MCL1 downregulation in YM155-treated human leukemia cells. Chiou JT; Lee YC; Huang CH; Shi YJ; Wang LJ; Chang LS Toxicol Appl Pharmacol; 2020 Jan; 387():114857. PubMed ID: 31837377 [TBL] [Abstract][Full Text] [Related]
8. ABT-263-induced MCL1 upregulation depends on autophagy-mediated 4EBP1 downregulation in human leukemia cells. Lee YC; Wang LJ; Huang CH; Shi YJ; Chang LS Cancer Lett; 2018 Sep; 432():191-204. PubMed ID: 29913235 [TBL] [Abstract][Full Text] [Related]
9. NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells. Chiou JT; Huang NC; Huang CH; Wang LJ; Lee YC; Shi YJ; Chang LS J Cell Physiol; 2021 Nov; 236(11):7356-7375. PubMed ID: 33982799 [TBL] [Abstract][Full Text] [Related]
10. GSK3β suppression inhibits MCL1 protein synthesis in human acute myeloid leukemia cells. Lee YC; Shi YJ; Wang LJ; Chiou JT; Huang CH; Chang LS J Cell Physiol; 2021 Jan; 236(1):570-586. PubMed ID: 32572959 [TBL] [Abstract][Full Text] [Related]
11. Quinacrine induces apoptosis in human leukemia K562 cells via p38 MAPK-elicited BCL2 down-regulation and suppression of ERK/c-Jun-mediated BCL2L1 expression. Changchien JJ; Chen YJ; Huang CH; Cheng TL; Lin SR; Chang LS Toxicol Appl Pharmacol; 2015 Apr; 284(1):33-41. PubMed ID: 25684043 [TBL] [Abstract][Full Text] [Related]
12. BCL2L1 inhibitor A-1331852 inhibits MCL1 transcription and triggers apoptosis in acute myeloid leukemia cells. Chiou JT; Wu YY; Lee YC; Chang LS Biochem Pharmacol; 2023 Sep; 215():115738. PubMed ID: 37562509 [TBL] [Abstract][Full Text] [Related]
13. SIRT3, PP2A and TTP protein stability in the presence of TNF-α on vincristine-induced apoptosis of leukaemia cells. Wang LJ; Chiou JT; Lee YC; Huang CH; Shi YJ; Chang LS J Cell Mol Med; 2020 Feb; 24(4):2552-2565. PubMed ID: 31930676 [TBL] [Abstract][Full Text] [Related]
14. Hydroquinone destabilizes BIM mRNA through upregulation of p62 in chronic myeloid leukemia cells. Lee YC; Chiou JT; Wang LJ; Chang LS Biochem Pharmacol; 2022 May; 199():115017. PubMed ID: 35346662 [TBL] [Abstract][Full Text] [Related]
15. Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition. Chiou JT; Lee YC; Chang LS Biochem Pharmacol; 2023 Dec; 218():115934. PubMed ID: 37989415 [TBL] [Abstract][Full Text] [Related]
16. Confounding off-target effects of BH3 mimetics at commonly used concentrations: MIM1, UMI-77, and A-1210477. Mallick DJ; Soderquist RS; Bates D; Eastman A Cell Death Dis; 2019 Feb; 10(3):185. PubMed ID: 30796196 [TBL] [Abstract][Full Text] [Related]
17. Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression. Chiou JT; Chang LS Apoptosis; 2024 Apr; 29(3-4):503-520. PubMed ID: 38066391 [TBL] [Abstract][Full Text] [Related]
18. Cytarabine-induced destabilization of MCL1 mRNA and protein triggers apoptosis in leukemia cells. Chiou JT; Hsu CC; Hong YC; Lee YC; Chang LS Biochem Pharmacol; 2023 May; 211():115494. PubMed ID: 36924905 [TBL] [Abstract][Full Text] [Related]
19. The suppressive effect of arsenic trioxide on TET2-FOXP3-Lyn-Akt axis-modulated MCL1 expression induces apoptosis in human leukemia cells. Chen YJ; Huang CH; Shi YJ; Lee YC; Wang LJ; Chang LS Toxicol Appl Pharmacol; 2018 Nov; 358():43-55. PubMed ID: 30213730 [TBL] [Abstract][Full Text] [Related]
20. Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents. Vrana JA; Cleaveland ES; Eastman A; Craig RW Apoptosis; 2006 Aug; 11(8):1275-88. PubMed ID: 16761109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]